SGK3 and major depressive disorder: First, SGKL treatment decreased the CRS‐increased immobile time and elevated the CRS‐repressed alterations of body weight, sugar preference, and rearing/crossing counts in the open‐field experiment, which revealed a significant role of SGKL treatment in depression‐like behaviors.